# Localized Neuropathic Pain: Topical Treatment Versus Systemic Treatment

> **NCT03348735** · PHASE4 · TERMINATED · sponsor: **University Hospital, Antwerp** · enrollment: 33 (actual)

## Conditions studied

- Neuropathic Pain

## Interventions

- **DRUG:** Lidocaine patch 5%
- **DRUG:** Capsaicin 8% Patch
- **DRUG:** Pregabalin

## Key facts

- **NCT ID:** NCT03348735
- **Lead sponsor:** University Hospital, Antwerp
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2018-12-03
- **Primary completion:** 2021-04-19
- **Final completion:** 2021-04-19
- **Target enrollment:** 33 (ACTUAL)
- **Why stopped:** Low inclusion rate
- **Last updated:** 2021-04-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03348735

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03348735, "Localized Neuropathic Pain: Topical Treatment Versus Systemic Treatment". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03348735. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*